Osage University Partners

oup.vc

VCMatch tracks Osage University Partners as an investor focused on Enterprise SaaS, Hardware, and Climate/Cleantech companies, Pre-Seed and Seed rounds, United States and International markets, and $1m to $20m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$1m to $20m

Stages

Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage

Focus Areas

Enterprise SaaS, Hardware, Climate/Cleantech

Geography

United States and International

Investment Thesis

OUP positions itself as a long‑term, hands‑on investor that specializes in commercializing research‑originated deep technology. The firm states it seeks to “provide capital and support to startups that are commercializing the most transformational and disruptive deep technology-based innovations,” and emphasizes converting lab discoveries into market‑ready products by drawing on a team of former scientists, operators and tech‑transfer experts. Their approach combines patient capital (reserving “meaningful capital for follow‑on rounds”), domain expertise, and close university relationships to move breakthrough research from campus to company.

Is Osage University Partners right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Osage University Partners is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Enterprise SaaS, Hardware, Climate/Cleantech, and Biotech, especially across United States and International, with public check-size signals around $1m to $20m.

Focus statement

OUP focuses on "breakthrough startups emerging from the world’s leading research labs and innovation ecosystems," investing across Tech (software, hardware, climate tech) and Life Science (therapeutics, medtech, diagnostics, research tools) at "all stages, from pre‑seed through crossover," typically in the $1–20M range.

Value Add

Deep university network: "Partnerships with 150+ universities and research institutions across the US and abroad" and repeated emphasis on university/tech‑transfer expertise.
Research‑to‑product specialization: explicit focus on "turning technology into product" and experience "converting technology into market‑winning products."
Team composition: investment team includes "former scientists, strategy consultants, and operators" and "tech transfer veterans," enabling technical diligence and commercialization support.
Proven track record and scale: cites ~$800M under management, "150+ portfolio companies" and "35+ successful IPOs, 9 approved medicines, and 11 approved medical products."
Founder‑friendly, hands‑on support: "We are not shy in introducing our companies to other investors and new hires" and they reserve capital for follow‑ons and work "side by side with founders."
Sector breadth across deep tech and life sciences, with explicit tooling for academic founders (EIR programs, university engagement).